EFFECT ·Filed Mar 11, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 4/10
Horizonweeks Processed6mo ago SEC9999999995-26-000767
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements that will disclose actual offering size, pricing, and use of proceeds. The effectiveness of the S-3 enables flexible capital raising, which could lead to near-term dilution if shares are issued.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
RCKT ▼ -41.13% at T+60d
NEUTRAL call ✗ call lost -41.13% · α vs SPY -52.65% · entry $4.96 → $2.92
Entry anchored
Mar 10, 03:59 PM ET
via exchange tick
T+1d
-0.81%
call -0.81% · α +0.68%
$4.92
settled 7mo ago
T+5d
-9.88%
call -9.88% · α -7.69%
$4.47
settled 7mo ago
T+20d
-27.42%
call -27.42% · α -27.94%
$3.60
settled 6mo ago
T+60d
-41.13%
call -41.13% · α -52.65%
$2.92
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Rocket Pharmaceuticals, Inc. has an effective shelf registration (Form S-3) as of March 10, 2026, allowing the company to issue unspecified securities from time to time. This creates a potential for future dilution, though no specific offering size or terms were disclosed.

Key Facts

  • Form S-3 shelf registration became effective on March 10, 2026.
  • The filing is a general offering statement, permitting the company to sell securities in one or more offerings without filing a new registration.
  • No specific offering size, pricing, or use of proceeds was disclosed in this filing.
  • The company may issue common stock, preferred stock, debt, or warrants under this shelf.

Financial Impact

Not specified

dilutionequitydebt

Risk Factors

  • Potential for unexpected equity issuance leading to shareholder dilution.
  • Market perception of a dilution overhang may pressure the stock price ahead of any offering.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000767
Document: 9999999995-26-000767-index.html9999999995-26-000767
Document: 9999999995-26-000767.txt9999999995-26-000767
12 reports for RCKT
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+20▲ +42.18%Jun 12, 2026
Filters
Rows
Reports for RCKT — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
8-K
BULLISH ★ 7/10
$3.41 $3.35▼ −1.76%▼ −3.89%$2.56 (−24.93%)
Aug 20, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.48 $3.62▲ +4.02%▲ +2.91%$2.56 (−26.44%)
Aug 17, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$3.34 $3.78▲ +13.17%▲ +13.37%$2.56 (−23.35%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.34 $3.48▲ +4.04%▲ +6.01%$2.56 (−23.35%)
Aug 10, 2026
7w ago
8-K
BULLISH ★ 7/10
$3.50 $3.34▼ −4.57%▼ −4.17%$2.56 (−26.86%)
Aug 3, 2026
8w ago
8-K
BULLISH ★ 6/10
$3.41 $3.64▲ +6.74%▲ +4.72%$2.56 (−24.93%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 2/10
$3.52 $4.07▲ +15.63%▲ +15.36%$2.56 (−27.27%)
Jun 12, 2026
16w ago
8-K
BULLISH ★ 5/10
$2.75 $3.35▲ +21.82%▲ +21.15%$2.56 (−6.91%)
May 26, 2026
18w ago
Insider Cluster
NEUTRAL ★ 3/10
$2.99 $2.92▼ −2.34%▼ −2.81%$2.56 (−14.38%)
May 7, 2026
21w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.25 $2.96▼ −8.92%▼ −9.89%$2.56 (−21.23%)
Showing 10 of 12

US Market Status

Market Closed — Opens Mon (65h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access